Is a complete SPTX research report available?

No complete published report is available for Seaport Therapeutics, Inc. (SPTX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Seaport Therapeutics, Inc. (SPTX)

NASDAQ: SPTX · USD

$21.1

-0.84 (-3.8%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-27 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first SPTX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	1.1B
Net income (ttm)	-87.2M
EPS (ttm)	-$11.6
Shares out	53.5M
Volume	53,530
Price target	$38.0	+80.1%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -87.2M
EPS (ttm): -$11.6
Market cap: 1.1B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All SPTX indicators

Market & fundamental data

Available fields

145

Groups with data

Currency

USD

Showing 145 of 145 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0002042347
Company name	Seaport Therapeutics, Inc.
Country	United States
Country code	US
Cusip	81221K108
Employees	58
Enterprise value	$952.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2026-05-01
Isin	US81221K1088
Last refreshed	2026-07-27
Market cap	$1.1B
Market cap category	Small-Cap
Price	$21.1
Price currency	USD
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.79
Sic	2834
Symbol	SPTX
Website	https://www.seaporttx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-7.72%
FCF yield	-6.92%
P/B ratio	5.39x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-87.2M
Net Income Growth Years	0%
Profit Per Employee	$-1.5M
ROCE	-40.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$227.7M
Cash	$182.6M
Current Assets	$188.3M
Current Liabilities	$14.2M
Debt	$5.3M
Debt Equity	$0.03
Equity	$209.7M
Liabilities	$18M
Long Term Assets	$39.3M
Long Term Liabilities	$3.7M
Net Cash	$177.3M
Net Cash By Market Cap	$15.69
Net Debt Equity	$-0.85
Tangible Book Value	$-115.6M
Tangible Book Value Per Share	$-44.55

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	13.24
Net Working Capital	$-6.9M
Quick ratio	13.07
Working Capital	$174.1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	18.8
All Time High	23
All Time High Change	-8.26%
All Time High Date	2026-05-01
All Time Low	14.85
All Time Low Change	42.09%
All Time Low Date	2026-05-07
ATR	1.64
Beta1y	-1.38
High	22.16
High52	23
High52 Date	2026-05-01
High52ch	-8.26%
Low	20.98
Low52	14.85
Low52 Date	2026-05-07
Low52ch	42.09%
Ma50ch	12.24%
RSI	54.5
RSI Monthly	0
RSI Weekly	0
Sharpe ratio	0.69x
Sortino ratio	1.12
Tr1m	11.23%
Tr1w	1.2%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Count Top	6
Analyst Price Target Top	$38.4
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.6
Operating Income	$-96.2M
Price target	$38
Price Target Change	$80.1
Price Target Change Top	$81.99

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	28,294,360%
Float Percent	52.86%
Shares Insiders	4.58%
Shares Institutions	12.76%
Shares Out	53,530,550
Shares Qo Q	5.73%
Short Float	9.82%
Short Ratio	11.66
Short Shares	5.19

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-86M
Average Volume	138,301.2x
Bv Per Share	-44.55
CAPEX	$-302,000
Ch1m	11.23
Ch1w	1.2
Change	-3.83%
Change From Open	-4.35
Close	21.94
Days Gap	0.55
Depreciation Amortization	163,000
Dollar Volume	1,129,483
Earnings Date	2026-09-04
Earnings Time	amc
EBIT	$-87.3M
EBITDA	$-87.1M
EPS	$-11.64
F Score	1
FCF	$-78.2M
FCF EV Yield	-8.21x
FCF Per Share	$-1.46
Financing CF	-1,656,000
Fiscal Year End	December
Founded	2,024
Income Tax	$1.3M
Investing CF	69,156,000
Ipr	17.22
Iprfo	0.48
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-06-08
Last Report Date	2026-03-31
Last Split Type	Never
Ma20	20.79
Ma20ch	1.48%
Net CF	-10,434,000
Next Earnings Date	2026-08-05
Open	22.06
Position In Range	10.17
Post Close	21.1
Postmarket Change Percent	-0.47
Postmarket Price	$21
Ppne	5,452,000
Price Date	2026-07-24
Relative Volume	0.39x
Share Based Comp	7,833,000
Us State	Massachusetts
Volume	53,530

Seaport Therapeutics, Inc. (SPTX)

Coverage state: Market snapshot only — no published research

Generate the first SPTX analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · SPTX

Valuation

Balance sheet

Trading

Next earnings

Sector percentile context

All SPTX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on SPTX

Frequently asked questions